These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7569482)

  • 1. The importance of tight blood glucose control in diabetes.
    Andersson DK
    Scand J Prim Health Care; 1995 Jun; 13(2):81-2. PubMed ID: 7569482
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose control in type 2 diabetes: still worthwhile and worth pursuing.
    Kahn SE
    JAMA; 2009 Apr; 301(15):1590-2. PubMed ID: 19366780
    [No Abstract]   [Full Text] [Related]  

  • 3. Duration of diabetes, glucose control and cardiovascular risk.
    Emanuele NV
    Diabetologia; 2010 Jan; 53(1):214-5. PubMed ID: 19841889
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].
    Lambiel J; Fumeaux T
    Rev Med Suisse; 2008 Aug; 4(166):1734. PubMed ID: 18777740
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic complications: current challenges and opportunities.
    Nickerson HD; Dutta S
    J Cardiovasc Transl Res; 2012 Aug; 5(4):375-9. PubMed ID: 22752737
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?
    Goodarzi MO; Psaty BM
    JAMA; 2008 Nov; 300(17):2051-3. PubMed ID: 18984894
    [No Abstract]   [Full Text] [Related]  

  • 7. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.
    De Feyter HM; Praet SF; van den Broek NM; Kuipers H; Stehouwer CD; Nicolay K; Prompers JJ; van Loon LJ
    Diabetes Care; 2007 Oct; 30(10):2511-3. PubMed ID: 17626892
    [No Abstract]   [Full Text] [Related]  

  • 8. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysglycaemia, cardiovascular outcome and treatment. Is the jury still out?
    Bartnik M; Cosentino F
    Eur Heart J; 2009 Jun; 30(11):1301-4. PubMed ID: 19395498
    [No Abstract]   [Full Text] [Related]  

  • 10. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
    Bajaj M; Jialal I
    Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
    [No Abstract]   [Full Text] [Related]  

  • 11. How to ADVANCE prevention of cardiovascular complications in type 2 diabetes.
    Grobbee DE
    Metabolism; 2003 Aug; 52(8 Suppl 1):24-8. PubMed ID: 12939736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction.
    Evid Based Med; 2015 Aug; 20(4):123. PubMed ID: 26209722
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetes and hypertension. Results from the ADVANCE study].
    Mehlsen J
    Ugeskr Laeger; 2008 Feb; 170(7):531-2. PubMed ID: 18291082
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular disease (CVD) limbo: how soon and low should we go to prevent CVD in diabetes?
    Maahs DM
    Diabetes Technol Ther; 2012 Jun; 14(6):449-52. PubMed ID: 22472062
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reduction of cardiovascular risk--a new approach in therapy of type 2 diabetes].
    Standl E
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():1. PubMed ID: 14694833
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward risk factor control for all patients with diabetes.
    Whitehouse F
    Diabetes Care; 1992 Nov; 15(11):1818-20. PubMed ID: 1468321
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiology patient pages. Cardiovascular disease in the diabetic patient.
    Goldfine AB; Goldfine HL
    Circulation; 2003 Jan; 107(2):e14-6. PubMed ID: 12538441
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction Between Non-Insulin Glucose-Lowering Medication and Exercise in Type 2 Diabetes Mellitus - New Findings on SGLT2 Inhibitors.
    Brinkmann C
    Front Endocrinol (Lausanne); 2021; 12():694099. PubMed ID: 34335470
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 20. Glycaemic control and macrovascular complications of type 2 diabetes.
    Dandona P; Chaudhuri A
    Natl Med J India; 2008; 21(6):271-4. PubMed ID: 19691214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.